MIPaste

Drug GC America Inc.
Total Payments
$36,817
Transactions
14
Doctors
10
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2022 $36,817 14 10

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $36,817 14 100.0%

Top Doctors Receiving Payments for MIPaste

Doctor Specialty Location Total Records
, DDS Dentist Newhall, CA $11,000 2
, D.D.S Dentist Parma, OH $6,500 2
, D.M.D., M.S Periodontics Yardley, PA $5,000 1
, DDS General Practice Yardley, PA $4,050 3
, DDS, FAGD General Practice Charlotte, NC $2,500 1
, D.D.S Pediatric Dentistry San Francisco, CA $2,000 1
, DDS, Dentist Castro Valley, CA $2,000 1
, DMD General Practice St George, UT $1,500 1
, DDS Oral and Maxillofacial Pathology Fargo, ND $1,267 1
, DDS General Practice Columbus, OH $1,000 1

About MIPaste

MIPaste is a drug associated with $36,817 in payments to 10 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is GC America Inc..

Payment data is available from 2022 to 2022. In 2022, $36,817 was paid across 14 transactions to 10 doctors.

The most common payment nature for MIPaste is "Honoraria" ($36,817, 100.0% of total).